A DESIGN FOR PHASE-II TESTING OF ANTICANCER AGENTS WITHIN A PHASE-III CLINICAL-TRIAL

被引：18
|
作者：
SCHAID, DJ [1 ]
INGLE, JN [1 ]
WIEAND, S [1 ]
AHMANN, DL [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
来源：
CONTROLLED CLINICAL TRIALS | 1988年 / 9卷 / 02期
关键词：
D O I：
10.1016/0197-2456(88)90032-3
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：107 / 118
页数：12
相关论文
共 50 条
  • [21] CLINICAL-TRIALS FOR ACUTE STROKE THERAPY - PHASE-II VERSUS PHASE-III TRIALS
    DIENER, HC
    HANTSON, L
    CEREBROVASCULAR DISEASES, 1995, 5 : 12 - 15
  • [22] LOCALLY ADVANCED BREAST-CANCER - REPORT OF PHASE-II STUDY AND SUBSEQUENT PHASE-III TRIAL
    RODGER, A
    JACK, WJL
    HARDMAN, PDJ
    KERR, GR
    CHETTY, U
    LEONARD, RCF
    BRITISH JOURNAL OF CANCER, 1992, 65 (05) : 761 - 765
  • [23] A PHASE-II CLINICAL-TRIAL OF CARBOPLATIN IN ADVANCED OVARIAN-CANCER
    POHL, J
    MEERPOHL, HG
    PFLEIDERER, A
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 61 - 61
  • [24] A SUMMARY OF CLINICAL PHASE-II AND PHASE-III STUDY RESULTS ON OFLOXACIN (HOE-280) IN EUROPE
    BLOMER, R
    BRUCH, K
    ZAHLTEN, RN
    INFECTION, 1986, 14 : S102 - S107
  • [25] METASTATIC PROSTATE-CANCER - PHASE-II CLINICAL-TRIAL OF SPIROGERMANIUM
    BUI, NB
    CHAUVERGNE, J
    BRUNET, R
    RICHAUD, P
    HOERNI, B
    LAGARDE, C
    LEGUILLOU, M
    BULLETIN DU CANCER, 1986, 73 (01) : 65 - 67
  • [26] PHASE-II AND PHASE-III STUDIES WITH CARBOPLATIN (JM8, CBDCA)
    CALVERT, AH
    WILTSHAW, E
    BAKER, JW
    SMITH, IE
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 105 - 105
  • [27] CARBOPLATIN AND IFOSFAMIDE IN OVARIAN-CANCER PHASE-II AND PHASE-III TRIALS
    WILTSHAW, E
    PERREN, TJ
    FRYATT, ID
    BLAKE, PR
    HARPER, P
    SLEVIN, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 : S48 - S50
  • [28] PHASE-III CLINICAL-TRIAL WITH NORPLANT(R)-II (2 COVERED RODS) - REPORT ON 5 YEARS OF USE
    BUCKSHEE, K
    CHATTERJEE, P
    DHALL, GI
    HAZRA, MN
    KODKANY, BS
    LALITHA, K
    LOGAMBAL, A
    MANCHANDA, P
    NANDA, UK
    CHOUDHURY, GR
    RAJARAM, P
    SENGUPTA, PC
    SIVARAMAN, R
    SUTARIA, UD
    ZAVERI, K
    DATEY, S
    GAUR, LN
    GUPTA, NK
    MENTA, S
    ROY, M
    SAXENA, NC
    YADAV, SC
    VISHWANATH, P
    CONTRACEPTION, 1993, 48 (02) : 120 - 132
  • [29] LIPOSOMAL AMPHOTERICIN-B (AMBISOME) - SAFETY DATA FROM A PHASE-II/III CLINICAL-TRIAL
    MEUNIER, F
    PRENTICE, HG
    RINGDEN, O
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 : 83 - 91
  • [30] TREATMENT OF HIGH-GRADE NON-HODGKIN LYMPHOMA - RESULTS OF A PHASE-II AND A PHASE-III TRIAL
    KOPPLER, H
    PFLUGER, KH
    HAVEMANN, K
    ESCHENBACH, I
    PFAB, R
    LENNERT, K
    WELLENS, W
    SCHMIDT, M
    GASSEL, WD
    KOLB, R
    HASSLER, R
    SCHUMACHER, K
    VONSPETH, G
    GROPP, C
    HIRSCHMANN, WD
    GOSSMANN, HH
    OHL, S
    DRINGS, P
    HOSSFELD, DK
    BRUNTSCH, U
    BLUT, 1988, 57 (04): : 220 - 220
12345